Azoy Alexander 4

What Happened

• Azoy Alexander, Chief Accounting Officer of Arcus Biosciences (RCUS), sold 2,562 shares on 2026-06-01 in open-market transactions. The weighted-average sale price was $25.77 per share, for total proceeds of approximately $66,024. The sales were reported on a Form 4 filed the same day.

Key Details

• Transaction date: 2026-06-01 (reported timely).
• Action: Sale (code S) — 2,562 shares sold; weighted average price $25.77; total ~$66,024.
• Price range: Shares were sold in multiple trades at prices between $25.67 and $25.90 (per filing).
• Prior purchase: Footnote indicates these 2,562 shares were purchased on 2026-05-29 through the company’s Employee Stock Purchase Plan (ESPP).
• Trading plan: Sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
• Ownership after sale: The filing notes owned shares include unvested RSUs, but the exact post-sale total is not specified in the provided summary (footnote references unvested RSU inclusion).

Context

• This was a sale executed under a pre-established 10b5-1 plan and involved recently acquired ESPP shares. Such automated plan sales and ESPP sell-offs are commonly routine and do not by themselves indicate insider sentiment about the company’s prospects.